Latest Glycoproteins Stories
This position paper discusses the benefits of the controversial hCG Protocol for Weight Loss, first instituted by British endocrinologist, Dr. A.T.W. Simeons in the 1950s, which uses the hCG hormone (Human Chorionic Gonadotropin) present in pregnant women to facilitate weight loss. Silver Spring, MD (PRWEB) August 08, 2012 Benjamin S. Gonzalez, MD, a board-certified physician and primary care practitioner, announced today the release of his position paper, “hCG Protocol for Healthy and...
FARMINGTON, Conn., Aug. 1, 2012 /PRNewswire-iReach/ -- Global Information Inc is pleased to announce limited available early bird discounted registration for three important international healthcare and biotechnology conferences: (Photo: http://photos.prnewswire.com/prnh/20120801/CG50305) PEGS Europe - Protein & Antibody Engineering Summit 2012 November 6-8, 2012 | Vienna, Austria The Fourth Annual Protein & Antibody Engineering Summit (PEGS Europe) presents an exciting opportunity...
LEBANON, N.H. and CAMBRIDGE, Mass., Aug. 1, 2012 /PRNewswire/ -- Adimab, LLC, the technology leader in the discovery and optimization of fully human therapeutic antibodies, and Mersana Therapeutics, Inc., a next-generation antibody-drug conjugate (ADC) company, today announced the initiation of a joint effort to offer integrated antibody discovery and ADC technologies. The alliance is built to offer pharmaceutical companies seamless access to Adimab's world-class antibodies that...
SEATTLE, July 31, 2012 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today reported that it believes it has identified the proteins that activate the alternative pathway of the complement system, an important part of the immune system. The work was led by the Company's collaborator, Professor Wilhelm Schwaeble of the University of Leicester, and Omeros controls the worldwide exclusive rights to this discovery. The complement system plays an important role in the inflammatory...
CRANBURY, N.J., July 30, 2012 /PRNewswire/ -- Oncobiologics, Inc. announced today a collaboration agreement with XOMA Corporation to develop novel biotherapeutics based on engineering single-chain variable fragments (scFv) into a bi-specific antibody scaffold. Through the partnership, Oncobiologics will utilize XOMA's ADAPT(TM) fully human antibody technology platform as a key component of its drug discovery program. Oncobiologics has selected clinically validated targets that will be...
A new study presented on July 17th, 2012, at the Alzheimer's Association International Conference 2012 in Vancouver revealed Alzheimer's disease symptoms long-term (three-year) stabilization with Gammagard. Gammagard, manufactured by Baxter, is an intravenous solution that is made from human plasma (intravenous immunoglobulin, or IVIG). It is a sterile solution, which helps the body maintain immunity and fight disease. In February 1994, Gammagard was pulled off from the global...
The hCG diet has been receiving a ton of attention in the media lately due to its proven weight loss properties. A leading premium brand of hCG diet supplement, HCG Excite, is now available to purchase online. Lakewood Range, FL (PRWEB) July 20, 2012 With the summer season fully underway, it is no wonder that thousands of individuals are using the hCG diet to lose weight fast. Anyone who has ever carried some extra weight in the summer season knows it can be embarrassing to join a pool...
Specialty biotech distributor BDI Pharma announced that Sales Revenues through the first two fiscal quarters of 2012 represented an increase of more than thirty-five percent (35%) compared with the same time period in 2011, with both Hemophilia and IVIG sales continuing to track ahead of 2011 in both revenue and units of distribution. Columbia, SC (PRWEB) July 19, 2012 BDI Pharma, Inc. (BDI), the nation's fastest growing national distributor of specialty biotherapeutics, announced...
CARLSBAD, Calif., July 19, 2012 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced it has signed a collaborative partnership with the Structural Genomics Consortium (SGC), and several groups of leading expert scientists in antibody technology at the Universities of Chicago and Toronto, to generate a first-ever master set of quality epigenetic recombinant antibodies for use in disease-related research. The first 58 of 200 highly-specific antibodies to be...
Researchers probe origin of optimized antibodies against infections An organism's ability to make new antibodies and use them to optimize its own immune defenses is of central importance in the fight against pathogens. In the case of severe infections, the overall relative speed with which an immune response proceeds could mean the difference between life and death. An international team of scientists, among them systems immunologist Prof. Michael Meyer-Hermann of the Helmholtz Centre for...
